Markets:

Overview

News

Currencies

International

Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

5.730 -0.770 (-11.85%)

Streaming Delayed Price Updated: 12:26 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Dow Climbs More Than 400 Points, S&P 500 Rises 1.5% ↗

September 09, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session ↗

September 09, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.

Via Benzinga

Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply ↗

September 09, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 09, 2022

During Friday's session, 41 companies made new 52-week lows.

Via Benzinga

NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million

September 09, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Recap: NovaBay Pharmaceuticals Q2 Earnings ↗

August 11, 2022

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results

August 11, 2022

From NovaBay® Pharmaceuticals, Inc.

Via Business Wire

Earnings Preview For NovaBay Pharmaceuticals ↗

August 10, 2022

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.

Via Benzinga

NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11

August 04, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions

July 28, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com

July 21, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event

July 15, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America

July 07, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2022

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

May 12, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Outlook For NovaBay Pharmaceuticals ↗

May 11, 2022

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations

May 09, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

May 05, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

April 25, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 21, 2022

Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

26 Stocks Moving in Thursday's Pre-Market Session ↗

April 21, 2022

Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...

Via Benzinga

23 Stocks Moving in Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS...

Via Benzinga

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment

April 11, 2022

From NovaBay Pharmaceuticals, Inc

Via Business Wire

NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line

April 01, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals's Return On Capital Employed Insights ↗

March 30, 2022

According to Benzinga Pro data, during Q4, NovaBay Pharmaceuticals (AMEX:NBY) posted sales of $2.64 million. Earnings were up 93.1%, but NovaBay Pharmaceuticals still reported an overall loss of...

Via Benzinga

NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results

March 29, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.